Avanos Medical, Inc. (AVNS) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

Earnings Reports

• Avanos (AVNS) Q4 2025: $30M Tariff Headwind Drives Supply Chain Pivot, Specialty Nutrition Outpaces Market
  February 25, 2026
• Avanos (AVNS) Q3 2025: Specialty Nutrition Surges 14.5% as Portfolio Reshaping Accelerates
  November 05, 2025
• Avanos (AVNS) Q2 2025: RFA Segment Grows 14%, Powering Portfolio Focus Post-HA Divestiture
  August 05, 2025
• Avanos (AVNS) Q2 2025: RFA Growth Hits 14% as HA Divestiture Refocuses Portfolio
  August 05, 2025
• Avanos Medical (AVNS) Q1 2025: $15M Tariff Hit Forces EPS Reset Despite 9% Nutrition Surge
  July 06, 2025
• Avanos Medical (AVNS) Q3 2024: Digestive Health Grows 6% as Transformation Offsets Pain Portfolio Setbacks
  October 30, 2024
• Avanos Medical (AVNS) Q2 2024: Digestive Health Grows 9%, Margin Expansion Signals Transformation Traction
  July 31, 2024
• AVNS Q1 2024: Digestive Health Delivers 9% Organic Growth, Margin Expansion Signals Transformation Traction
  May 02, 2024
• AVNS Q4 2023: HA Portfolio Down 35% as Transformation Targets Margin Expansion
  February 20, 2024

Browse all companies